We previously reported that constitutive genetic deletion of SNCA in the J20 transgenic mouse model of AD rescues premature mortality, memory and synaptic deficits despite an exacerbation of amyloid pathology [25]. This evidence concerns the gene SNCA and Alzheimer disease.